BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23555315)

  • 1. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
    Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
    PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
    BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
    Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
    J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
    Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
    Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation.
    Kim Y; Suktitipat B; Yanek LR; Faraday N; Wilson AF; Becker DM; Becker LC; Mathias RA
    PLoS One; 2013; 8(5):e64179. PubMed ID: 23704978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
    Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
    Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
    PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
    Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
    Zeng C; Guo X; Long J; Kuchenbaecker KB; Droit A; Michailidou K; Ghoussaini M; Kar S; Freeman A; Hopper JL; Milne RL; Bolla MK; Wang Q; Dennis J; Agata S; Ahmed S; Aittomäki K; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Arun BK; Arver B; Bacot F; Barrowdale D; Baynes C; Beeghly-Fadiel A; Benitez J; Bermisheva M; Blomqvist C; Blot WJ; Bogdanova NV; Bojesen SE; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brennan P; Brenner H; Broeks A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldes T; Campbell I; Carpenter J; Chang-Claude J; Choi JY; Claes KB; Clarke C; Cox A; Cross SS; Czene K; Daly MB; de la Hoya M; De Leeneer K; Devilee P; Diez O; Domchek SM; Doody M; Dorfling CM; Dörk T; Dos-Santos-Silva I; Dumont M; Dwek M; Dworniczak B; Egan K; Eilber U; Einbeigi Z; Ejlertsen B; Ellis S; Frost D; Lalloo F; ; Fasching PA; Figueroa J; Flyger H; Friedlander M; Friedman E; Gambino G; Gao YT; Garber J; García-Closas M; Gehrig A; Damiola F; Lesueur F; Mazoyer S; Stoppa-Lyonnet D; ; Giles GG; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Haiman CA; Hallberg E; Hamann U; Hansen TV; Hart S; Hartikainen JM; Hartman M; Hassan N; Healey S; Hogervorst FB; Verhoef S; ; Hendricks CB; Hillemanns P; Hollestelle A; Hulick PJ; Hunter DJ; Imyanitov EN; Isaacs C; Ito H; Jakubowska A; Janavicius R; Jaworska-Bieniek K; Jensen UB; John EM; Joly Beauparlant C; Jones M; Kabisch M; Kang D; Karlan BY; Kauppila S; Kerin MJ; Khan S; Khusnutdinova E; Knight JA; Konstantopoulou I; Kraft P; Kwong A; Laitman Y; Lambrechts D; Lazaro C; Le Marchand L; Lee CN; Lee MH; Lester J; Li J; Liljegren A; Lindblom A; Lophatananon A; Lubinski J; Mai PL; Mannermaa A; Manoukian S; Margolin S; Marme F; Matsuo K; McGuffog L; Meindl A; Menegaux F; Montagna M; Muir K; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Newcomb PA; Nord S; Nussbaum RL; Offit K; Olah E; Olopade OI; Olswold C; Osorio A; Papi L; Park-Simon TW; Paulsson-Karlsson Y; Peeters S; Peissel B; Peterlongo P; Peto J; Pfeiler G; Phelan CM; Presneau N; Radice P; Rahman N; Ramus SJ; Rashid MU; Rennert G; Rhiem K; Rudolph A; Salani R; Sangrajrang S; Sawyer EJ; Schmidt MK; Schmutzler RK; Schoemaker MJ; Schürmann P; Seynaeve C; Shen CY; Shrubsole MJ; Shu XO; Sigurdson A; Singer CF; Slager S; Soucy P; Southey M; Steinemann D; Swerdlow A; Szabo CI; Tchatchou S; Teixeira MR; Teo SH; Terry MB; Tessier DC; Teulé A; Thomassen M; Tihomirova L; Tischkowitz M; Toland AE; Tung N; Turnbull C; van den Ouweland AM; van Rensburg EJ; Ven den Berg D; Vijai J; Wang-Gohrke S; Weitzel JN; Whittemore AS; Winqvist R; Wong TY; Wu AH; Yannoukakos D; Yu JC; Pharoah PD; Hall P; Chenevix-Trench G; ; ; Dunning AM; Simard J; Couch FJ; Antoniou AC; Easton DF; Zheng W
    Breast Cancer Res; 2016 Jun; 18(1):64. PubMed ID: 27459855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.
    Waters KM; Le Marchand L; Kolonel LN; Monroe KR; Stram DO; Henderson BE; Haiman CA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1285-9. PubMed ID: 19318432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphB2 SNPs and sporadic prostate cancer risk in African American men.
    Robbins CM; Hooker S; Kittles RA; Carpten JD
    PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
    Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
    BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-ethnic transcriptome-wide association study of prostate cancer.
    Fiorica PN; Schubert R; Morris JD; Abdul Sami M; Wheeler HE
    PLoS One; 2020; 15(9):e0236209. PubMed ID: 32986714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication and heritability of prostate cancer risk variants: impact of population-specific factors.
    Virlogeux V; Graff RE; Hoffmann TJ; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):938-43. PubMed ID: 25809866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions.
    Han Y; Hazelett DJ; Wiklund F; Schumacher FR; Stram DO; Berndt SI; Wang Z; Rand KA; Hoover RN; Machiela MJ; Yeager M; Burdette L; Chung CC; Hutchinson A; Yu K; Xu J; Travis RC; Key TJ; Siddiq A; Canzian F; Takahashi A; Kubo M; Stanford JL; Kolb S; Gapstur SM; Diver WR; Stevens VL; Strom SS; Pettaway CA; Al Olama AA; Kote-Jarai Z; Eeles RA; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; Isaacs WB; Chen C; Lindstrom S; Le Marchand L; Giovannucci EL; Pomerantz M; Long H; Li F; Ma J; Stampfer M; John EM; Ingles SA; Kittles RA; Murphy AB; Blot WJ; Signorello LB; Zheng W; Albanes D; Virtamo J; Weinstein S; Nemesure B; Carpten J; Leske MC; Wu SY; Hennis AJ; Rybicki BA; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Zheng SL; Witte JS; Casey G; Riboli E; Li Q; Freedman ML; Hunter DJ; Gronberg H; Cook MB; Nakagawa H; Kraft P; Chanock SJ; Easton DF; Henderson BE; Coetzee GA; Conti DV; Haiman CA
    Hum Mol Genet; 2015 Oct; 24(19):5603-18. PubMed ID: 26162851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.